Reminder: Login to access new features and members-only content!

Register to be a member of our community. Its easy!

Register a new account

Already a member?

Log In here!

Donate

Did you find our content interesting or helpful? Help support the IPFD enhance health, well-being and welfare for dogs everywhere.

Jump to content
  •   Language
  • Sign Up

International Partnership for Dogs - Enhancing Dog Health, Well-Being, and Welfare - Join Us.

Neuropathy, Sensory

Breeds

Relevance Rating: The test is unknown, there is no evidence (i.e. research) available, or it has not been evaluated yet. These tests may or may not be meaningful in this breed

General

Disease Name
Neuropathy, Sensory
Mutation
6.47 Mb inversion
Test Type
Genetic Disease/Disorder
Details
Sensory neuropathy (SN) causes severe, progressive degeneration of sensory and motor nerve cells. Signs include: knuckling of the feet, self-mutilation, excessive licking, progressive ataxia, and a progressive loss of sensation in limbs - progressing to include incontinence and regurgitation. Age of onset 2-7 months. As quality of life is severely affected, dogs with SN are euthanised before two years of age.
Details 2
Sensory neuropathy in the Border Collie is a severe neurological disorder caused by the degeneration of sensory and, to a lesser extent, motor nerve cells with clinical signs starting between 2 and 7 months of age... Through mutation screening, it should be possible to reduce the frequency of or completely eliminate this debilitating condition from the Border Collie breed population. (From Forman et al, 2017)
Published
Forman, O.P., Hitti, R.J., Pettitt, L., Jenkins, C.A., O'Brien, D.P., Shelton, G.D., De Risio, L., Gutierrez Quintana, R., Beltran, E., Mellersh, C. : An Inversion Disrupting FAM134B Is Associated with Sensory Neuropathy in the Border Collie Dog Breed. G3 (Bethesda) :, 2016. Pubmed reference: 27527794. DOI: 10.1534/g3.116.027896.

Breed Specific Info

Breed-specific 1
Border Collie
×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use.